AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants
APA:Jena BR, Panda SP, Kulandaivelu U, Alavala RR, Rao GSNK, Swain S, Pattnaik G, Ghose D.. (Volume-18, Issue-6 -(Year-2021)). AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants. Retrieved from https://pubmed.ncbi.nlm.nih.gov/34978401/
Chicago:Jena BR, Panda SP, Kulandaivelu U, Alavala RR, Rao GSNK, Swain S, Pattnaik G, Ghose D.. "AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants" Example, Volume-18-issue-6-Year-2021-2148-6247. https://pubmed.ncbi.nlm.nih.gov/34978401/.
